Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies

Posted on by

New entity offers U.S. partners the convenience of local presence with the advantages of international expertise Novel developability assessment and pre-formulation platform services shorten time to market and de-risk drug product development projects MARTINSRIED-MUNICH, Germany, May 29,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.